The Allergy / Immunology Channel

Public Health Advisory on Chantix

Adverse events report

1:02 | Allergy / Immunology, Psychiatry & Mental Health, Pulmonary Medicine

The FDA issued a Public Health Advisory to alert health care providers, patients, and caregivers to new safety warnings concerning Chantix (varenicline), a prescription medication used to help patients stop smoking.

References and Resources
FDA Issues Public Health Advisory on Chantix

More in Allergy / Immunology

► 1:59

Immunological Mechanism Defense Against COPD Pathogens

Allergy / Immunology

Results from a study led by Daniel Enosi Tuipulotu, BSc, a postdoctoral fellow at the John Curtin School of Medical Research, Australian National University, Canberra, demonstrated that Moraxella catarrhalis, a...

► 1:18:26

CDC Advisory Committee on Immunization Practices: Influenza 2022-2023

Allergy / Immunology

In a meeting of the Advisory Committee on Immunization Practices in March 2023, the focus was on the respiratory disease surge in Fall 2022 in the United States, with presentations...

► 5:43:30

FDA VRBPAC Meeting: RSV Treatment

Allergy / Immunology

The focus of the 179th Meeting of Vaccines and Related Biological Products Advisory Committee was on the biologics license application for respiratory syncytial virus (RSV) vaccine recombinant, Adjuvanted (AREXVY). Experts...

► 28:43

Viral Therapy & Immunotherapy

Allergy / Immunology

Rimas V. Lukas, MD, associate chief, neuro-oncology division, Malnati Brain Tumor Institute, Northwestern University, Chicago, IL, discusses current and emerging research on the use of immunotherapy and oncolytic viruses for...